how many people in us are on glp 1 According to the poll, the share of U.S. adults currently taking GLP-1 medications for weight loss has climbed to 11% 2026, up from 3% just two years ago. 🔗⬇️ New Weight Loss Drugs: GLP-1

Another meta-analysis demonstrated that L-carnitine supplementation is not associated with significant reductions in serum concentrations of TC, HDL, very LDL, and TG, but can significantly reduce LDL levels in patients undergoing hemodialysis (Huang et al., 2013)

It acts like growth hormone-releasing hormone (GHRH) to trigger the pituitary gland, helping naturally boost the GH your body already produces

If you are traveling internationally, check local regulations on injectable medications before departure, as some countries restrict GLP-1 compounds

Your healthcare provider can help you weigh these risk factors against the potential benefits to determine if these medications align with your health goals

Koureta E, Cholongitas E

North America dominated the global GLP-1 receptor agonist market share by 76% in 2025